© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Atropine Sulfate Monohydrate stands out as a well-known antimuscarinic agent, primarily derived from plants like Atropa belladonna. This substance often appears in the form of colorless or white crystals, powder, or even translucent flakes. At room temperature, it behaves as a stable solid, but its application stretches across medical and research settings. The compound goes by the molecular formula C17H23NO3·H2SO4·H2O, carrying a molecular weight close to 433.5 g/mol. Unlike certain volatile chemicals, it does not emit a strong odor, which makes handling in clinical and industrial laboratories more straightforward. What draws attention in its chemical makeup lies in the sulfate group bonded to atropine base and a singular molecule of water that influences its crystal lattice.
This substance typically forms crystals that can be ground into a white, fine powder. Some batches come as granular pearls or solid, dense flakes. It dissolves quickly in water, giving a clear solution, yet its taste remains notably bitter. Density measures around 1.5 g/cm³. This characteristic is particularly important for laboratories seeking to dose specific concentrations in solution form per liter. Compared to other alkaloid salts, Atropine Sulfate Monohydrate remains stable under most storage conditions, showing minimal degradation or color change. The melting point sits between 190-194°C, suggesting it resists decomposition in most ambient scenarios, though direct exposure to high temperatures or strong acids changes its stability profile. For industries or institutions receiving raw materials in various forms, recognizing these properties helps avoid waste or contamination from improper handling.
The material’s chemical structure features a tropane ring alongside a sulfate group and coordinated water molecule. This setup affects its solubility; labs have found it dissolves fully in water at concentrations necessary for injectable pharmaceutical products. In other solvents like ethanol, it disperses but not as thoroughly. The monohydrate form generally crystallizes in elongated plates or thin needles, a trait used to distinguish it from other atropine derivatives. Under ultraviolet light, it doesn’t fluoresce, helping with basic identification tests. These physical cues prevent misidentification and accidental substitution in complex chemical workflows.
The quality of Atropine Sulfate Monohydrate depends largely on purity, with the pharmaceutical level requiring a minimum of 98%. Modern documentation places it under the HS Code 2939.19.00, aligning with international guidelines for alkaloid-based compounds. Manufacturing processes must minimize the presence of related impurities and control moisture, since excess water beyond the monohydrate state can alter the effective dose. Most reputable suppliers offer detailed specification sheets, providing batch-level data on particle size, residual solvents, and trace heavy metals. Complying with both the United States Pharmacopeia (USP) and European Pharmacopeia (Ph. Eur.) increases trust among researchers and clinicians.
Atropine Sulfate Monohydrate is potent and, at certain levels, classified as hazardous. Direct skin or eye contact produces irritation, while accidental inhalation or ingestion leads to anticholinergic symptoms, some of which prove dangerous without prompt medical attention. Its lethal dose (LD50) falls within microgram to milligram levels per kilogram in animal studies, a figure highlighting the importance of precise dosing equipment. Wearing gloves, goggles, and using fume extraction or respirators when working with dry powder remains essential. Spill cleanup protocols often rely on diluting small quantities with water before neutralization and absorption into inert sand for disposal as hazardous waste. Storage should avoid light and temperature extremes, and keep the material in tightly sealed, labeled, HDPE or amber glass containers, away from acids or bases that initiate decomposition.
Producing Atropine Sulfate Monohydrate begins with extracting crude atropine from plant sources followed by chemical reaction with dilute sulfuric acid in a controlled, aqueous environment. This process generates the monohydrate form, which then undergoes further purification, crystallization, filtration, and drying. Each production stage requires high-precision measurements and modern quality assurance practices to ensure uniformity. Pharmaceutical manufacturers use the compound in making injectable antidotes for organophosphate poisoning, ophthalmic solutions for pupil dilation, and pre-surgery medications to reduce salivation. Academic and medical research settings also depend on it for in vitro experiments involving parasympathetic blockade or muscarinic receptor studies. Its unique properties demand strict adherence to safe handling principles, quality specification checks, and intelligent lifecycle management — from procurement of raw plant material to drug formulation.
